ANKAMYCIN Trademark

Trademark Overview

On Thursday, April 6, 2017, a trademark application was filed for ANKAMYCIN with the United States Patent and Trademark Office. The USPTO has given the ANKAMYCIN trademark a serial number of 87401521. The federal status of this trademark filing is REGISTERED as of Tuesday, January 8, 2019. This trademark is owned by CIPLA LIMITED. The ANKAMYCIN trademark is filed in the Pharmaceutical Products category with the following description:

(Based on 44(e)) Pharmaceutical products for the treatment of bacterial infections
ankamycin

General Information

Serial Number87401521
Word MarkANKAMYCIN
Filing DateThursday, April 6, 2017
Status700 - REGISTERED
Status DateTuesday, January 8, 2019
Registration Number5646206
Registration DateTuesday, January 8, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 17, 2018

Trademark Statements

Goods and Services(Based on 44(e)) Pharmaceutical products for the treatment of bacterial infections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 13, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCIPLA LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMumbai, Maharashtra 400013
IN
Party NameCIPLA LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMumbai, Maharashtra 400013
IN
Party NameCIPLA LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMumbai, Maharashtra 400013
IN

Trademark Events

Event DateEvent Description
Monday, January 8, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 8, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, December 4, 20181(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, November 1, 2018NOTICE OF ALLOWANCE CANCELLED
Tuesday, December 4, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 1, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, June 12, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, March 11, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 10, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 9, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 9, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, February 26, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, February 26, 2018FINAL REFUSAL E-MAILED
Monday, February 26, 2018FINAL REFUSAL WRITTEN
Tuesday, February 13, 2018ASSIGNED TO EXAMINER
Thursday, January 18, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 18, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 11, 2018ASSIGNED TO LIE
Friday, December 22, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 29, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 29, 2017NON-FINAL ACTION E-MAILED
Thursday, June 29, 2017NON-FINAL ACTION WRITTEN
Tuesday, June 27, 2017ASSIGNED TO EXAMINER
Thursday, April 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 10, 2017NEW APPLICATION ENTERED

Related Keywords

ankamycin bacterial infections treatment products pharmaceutical based